Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Carbonic anhydrase 1 (CA1) is a cytosolic enzyme belonging to the alpha-carbonic anhydrase subfamily. It plays a crucial role in cellular pH regulation and CO2 transport. CA1 is highly expressed in red blood cells and has been implicated in cardiovascular complications of diabetes, as well as ocular diseases. Its dysregulation contributes directly to several disease states including cardiovascular complications from diabetes as well as ocular diseases involving vascular leakage.
Catalyzes the reversible hydration of carbon dioxide to bicarbonate and protons.
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Carbonic Anhydrase 1 (CA1).